全文获取类型
收费全文 | 885篇 |
免费 | 60篇 |
国内免费 | 43篇 |
专业分类
林业 | 64篇 |
农学 | 76篇 |
基础科学 | 32篇 |
85篇 | |
综合类 | 285篇 |
农作物 | 60篇 |
水产渔业 | 25篇 |
畜牧兽医 | 261篇 |
园艺 | 18篇 |
植物保护 | 82篇 |
出版年
2024年 | 4篇 |
2023年 | 20篇 |
2022年 | 13篇 |
2021年 | 32篇 |
2020年 | 24篇 |
2019年 | 40篇 |
2018年 | 14篇 |
2017年 | 23篇 |
2016年 | 40篇 |
2015年 | 34篇 |
2014年 | 61篇 |
2013年 | 68篇 |
2012年 | 86篇 |
2011年 | 69篇 |
2010年 | 52篇 |
2009年 | 49篇 |
2008年 | 45篇 |
2007年 | 46篇 |
2006年 | 29篇 |
2005年 | 28篇 |
2004年 | 28篇 |
2003年 | 27篇 |
2002年 | 14篇 |
2001年 | 21篇 |
2000年 | 14篇 |
1999年 | 12篇 |
1998年 | 7篇 |
1997年 | 7篇 |
1996年 | 8篇 |
1995年 | 14篇 |
1994年 | 7篇 |
1993年 | 7篇 |
1992年 | 5篇 |
1991年 | 8篇 |
1990年 | 3篇 |
1989年 | 6篇 |
1988年 | 6篇 |
1987年 | 4篇 |
1986年 | 1篇 |
1985年 | 5篇 |
1984年 | 2篇 |
1982年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1976年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有988条查询结果,搜索用时 328 毫秒
41.
不同温度下亚洲玉米螟实验种群生命表 总被引:7,自引:0,他引:7
为更有效地防治玉米螟,了解玉米螟在不同温度下的生长发育和繁殖情况尤为重要。在实验室中设置5个恒温(35℃、30℃、25℃、20℃、15℃)环境,相对湿度为75%,研究不同温度对亚洲玉米螟各虫态生长发育的影响,组建玉米螟实验种群生命表。试验结果表明,玉米螟卵的孵化率、幼虫存活率和羽化率在25℃下均为最高,繁殖力也在25℃下达到最大值;在15~30℃温度范围下玉米螟各虫态的发育历期随温度升高而缩短,温度过高会抑制其生长速度;净生殖力(R0)和内禀增长率(rm)分别在36.80~60.14和0.07~0.10之间,且25℃下的这两项指标最高;根据生命表显示,玉米螟种群趋势指数与繁殖天数呈抛物线趋势,在25℃时种群趋势指数达到最大。据此可知,25℃为最适宜玉米螟生长发育和繁殖的温度。 相似文献
42.
马明涛 《吉林农业科技学院学报》2013,(4):97-99
介绍了吉林农业科技学院电子电工实验室(中心)建设发展的历程及实践教学体系的建立.具体从分层次实验教学体系、实验教学方法与手段、师资队伍等多方面进行了论述,展现一个“新建”本科院校的成长过程. 相似文献
43.
Overestimation of canine albumin concentration with the bromcresol green method in heparinized plasma samples 总被引:5,自引:0,他引:5
Stokol T Tarrant JM Scarlett JM 《Veterinary clinical pathology / American Society for Veterinary Clinical Pathology》2001,30(4):170-176
Albumin concentrations are routinely measured in dogs with bromcresol green (BCG)-binding assays on automated chemistry analyzers. Several variables affect this assay, including the length of reaction time, sample type, and lack of specificity of BCG for albumin. We observed that albumin concentrations measured with BCG appeared higher in heparinized plasma samples in sick dogs. The objective of this study was to determine the effect of anticoagulant and assay procedure on BCG albumin concentrations in clinically ill dogs. We hypothesized that albumin concentrations would be overestimated in heparinized plasma compared with serum because of the combination of heparin and fibrinogen. Furthermore, we hypothesized that the overestimation would be influenced by assay parameters. Blood was collected from 32 clinically ill dogs into tubes containing heparin, citrate, or no anticoagulant. Citrate was chosen to assess the effect of fibrinogen in the absence of heparin. Albumin concentration was measured in all 3 sample types from each dog using 2 different BCG procedures on an automated chemistry analyzer. The BCG procedures (standard and modified) differed in the wavelengths used for absorbance readings (standard, 600/700; modified, 570/505) and the time point at which absorbance was measured (standard, 100 seconds; modified, 40 seconds). In addition, the modified method incorporated a sample blank. Globulin fractions, fibrinogen concentration, and indices of lipemia, hemolysis, and icterus were evaluated for their contribution to the overestimation of albumin concentration in heparinized plasma compared with serum samples. Albumin concentrations were significantly higher (P =.05) in heparinized plasma (mean +/- SE, 3.8 +/- 0.1 g/dL) than in serum (3.6 +/- 0.2 g/dL) or citrated plasma (3.2 +/- 0.1 g/dL). Overestimation was evident only with the standard BCG procedure. Multiple linear regression analysis indicated that fibrinogen was largely responsible for the higher albumin concentration in heparinized plasma with the standard method. Based on these results, heparin is not recommended as an anticoagulant for albumin measurement in dogs when using a BCG method unless the assay uses a sample blank and a reaction time of <1 minute. 相似文献
44.
A field trials programme was conducted in which the performance of a new emulsifiable concentrate formulation (ECI) of flamprop-M-isopropyl containing the adjuvant, ‘Dobanol’ 25-7, in a ratio of 2:1 (by weight) with the AI, was compared with the current commercial formulation of ‘Commando’, in combination with its recommended adjuvant, ‘Swirl’, for the control of wild oat (Avena fatua L.) in wheat (Triticum aestivum L.) and barley (Hordeum vulgare L.). A further treatment, in which the ‘Dobanol’ 25-7: AI ratio was increased to 4:1 by the spray tank addition of the former, was also included. The mean results from six trials (five wheat, one barley) showed that the addition of ‘Swirl’ to ‘Commando’ was beneficial, increasing wild oat floret control from a mean value of 80% to 92% at current recommended rates (flamprop-M-isopropyl, 600 g ha?1; ‘Swirl’, 2.5 litre ha?1). However, combinations of flamprop-M-isopropyl and ‘Dobanol’ 25-7 gave superior levels of control even at lower AI application rates. For example, a mean level of 96% control of Avena spp. was obtained at 300 g AI ha?1 with 1200 g ha?1 ‘Dobanol’ 25–7; with even better control at higher rates of application of both components. This improvement in performance was accompanied by a higher risk of crop phytotoxicity than observed with the ‘Commando’/‘Swirl’ mixtures. Symptoms initially were scorch and subsequently growth depression, particularly of tillers. None of the mean values in the six ‘efficacy’ trials reached commercially unacceptable levels, but in a further six ‘crop effects’ trials (three wheat, three barley), in which double rates were applied, the levels of phytotoxicity did become unacceptable and subsequently reduced grain yields. In contrast, two barley ‘crop effects’ trials gave yields higher than the control plots, possibly through the effects of reducing stem length and lodging thereby enabling more efficient harvesting. Nevertheless, there were rates of application of flamprop-M-isopropyl in the range 300–400 g ha?1 with ratios of ‘Dobanol’ 25-7 in the range 2:1 to 4:1 that would achieve high levels of control of Avena spp. without undue risk of crop phytotoxicity and further trials are planned to support this new adjuvant system. 相似文献
45.
Cynthia M. Otto DVM PhD DACVECC 《Journal of Veterinary Emergency and Critical Care》2007,17(4):359-367
Objective: To provide evidence that naturally occurring sepsis in dogs provides a unique opportunity to test new therapies in clinically relevant settings. Data sources: Human and veterinary literature. Human data synthesis: Sepsis is a devastating condition responsible for most intensive care unit deaths. Most clinical trials targeting inflammatory mediators of sepsis have failed to improve outcome in clinical patients despite promising results in laboratory animal models. Animal models of sepsis fail to reproduce the clinical syndrome and therefore lead to conclusions that may not be relevant to clinical care. Veterinary data synthesis: Sepsis is recognized but not well‐characterized in companion animal species. Despite some species variability, the cardiopulmonary response to sepsis in dogs is similar to humans. Additionally, inflammatory and coagulation changes that accompany canine sepsis are consistent with those documented in humans. Sepsis secondary to canine parvoviral infection offers the advantages of relative population homogeneity, predictable course, and easy early diagnosis. The disadvantages of canine parvovirus are that it affects a predominantly young and healthy population and results in low mortality with aggressive supportive care. Septic peritonitis and pneumonia have high mortality but can be challenging to diagnose, have a variable course, and affect a heterogeneous population, which can be an advantage or a disadvantage. Conclusions: Similar to trials currently being performed in canine cancer patients, veterinary clinical trials of new sepsis therapeutics may provide a unique opportunity to advance the treatment of sepsis in dogs, humans, and other species. Spontaneous sepsis from canine parvovirus, peritonitis, and pneumonia are common clinical conditions in which therapeutics can be tested. 相似文献
46.
47.
48.
49.
介绍了模拟化学实验室在绿色化学教育中的重要性,分析了模拟化学实验的优势与作用。 相似文献
50.
Diagnostic testing is routinely performed by the equine clinician when dealing with suspected infectious disease cases and outbreaks. Optimal sample timing, choice and handling are fundamental to attain an accurate diagnosis, and a good understanding of laboratory-based sample analysis techniques, and their validation is necessary for effective diagnostic test result interpretation. This two-part series highlights the importance of interpreting results bearing testing limitations and specific clinical findings in mind, and on these foundations, the treating clinician should always be well placed to deal with equine infectious diseases. Part 1 in this series will provide a treating clinician with an overview of the importance of testing horses in infectious disease outbreaks and how this is achieved. The different laboratory testing options available for agent detection and their methods will also be discussed. Part 2 will summarise serological (antibody) testing techniques, sample processing (including how tests are performed and validated) and result interpretation. 相似文献